Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Schenone

Showing results (71-80 of 173) with videos related to

Pageof 18
Sort By:
Drug Metabolism and Pharmacokinetics|May 23, 2014
CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reactionClaudio Zamperini, Elena Dreassi, Giulia Vignaroli, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2017
Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: Preparation, characterization and cytotoxicity evaluation against neuroblastoma cell lineAnna Lucia Fallacara, Arianna Mancini, Claudio Zamperini, et al.
European Journal of Medicinal Chemistry|October 29, 2008
Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitorsAndrea Spallarossa, Sara Cesarini, Angelo Ranise, et al.
Molecules (Basel, Switzerland)|April 27, 2024
Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular ModelingGiancarlo Grossi, Naomi Scarano, Francesca Musumeci, et al.
European Journal of Medicinal Chemistry|October 26, 2010
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitorsElena Dreassi, Alessandra Tania Zizzari, Mattia Mori, et al.
Organic & Biomolecular Chemistry|July 13, 2005
New pyrazolo[3,4-b]pyridones as selective A(1) adenosine receptor antagonists: synthesis, biological evaluation and molecular modelling studiesPaola Fossa, Marco Pestarino, Giulia Menozzi, et al.
Bioorganic & Medicinal Chemistry|May 27, 2008
Parallel one-pot synthesis and structure-activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitorsSara Cesarini, Andrea Spallarossa, Angelo Ranise, et al.
Chemmedchem|February 14, 2007
Inhibition of Bcr-Abl phosphorylation and induction of apoptosis by pyrazolo[3,4-d]pyrimidines in human leukemia cellsFabrizio Manetti, Annalisa Pucci, Matteo Magnani, et al.
Journal of Medicinal Chemistry|February 21, 2003
Design, synthesis, SAR, and molecular modeling studies of acylthiocarbamates: a novel series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors structurally related to phenethylthiazolylthiourea derivativesAngelo Ranise, Andrea Spallarossa, Silvia Schenone, et al.
Future Medicinal Chemistry|December 16, 2014
The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channelErika Nieddu, Benedetta Pollarolo, Marco T Mazzei, et al.
Pageof 18

Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
Drug Metabolism and Pharmacokinetics|May 23, 2014
CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reactionClaudio Zamperini, Elena Dreassi, Giulia Vignaroli, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2017
Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: Preparation, characterization and cytotoxicity evaluation against neuroblastoma cell lineAnna Lucia Fallacara, Arianna Mancini, Claudio Zamperini, et al.
European Journal of Medicinal Chemistry|October 29, 2008
Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitorsAndrea Spallarossa, Sara Cesarini, Angelo Ranise, et al.
Molecules (Basel, Switzerland)|April 27, 2024
Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular ModelingGiancarlo Grossi, Naomi Scarano, Francesca Musumeci, et al.
European Journal of Medicinal Chemistry|October 26, 2010
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitorsElena Dreassi, Alessandra Tania Zizzari, Mattia Mori, et al.
Organic & Biomolecular Chemistry|July 13, 2005
New pyrazolo[3,4-b]pyridones as selective A(1) adenosine receptor antagonists: synthesis, biological evaluation and molecular modelling studiesPaola Fossa, Marco Pestarino, Giulia Menozzi, et al.
Bioorganic & Medicinal Chemistry|May 27, 2008
Parallel one-pot synthesis and structure-activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitorsSara Cesarini, Andrea Spallarossa, Angelo Ranise, et al.
Chemmedchem|February 14, 2007
Inhibition of Bcr-Abl phosphorylation and induction of apoptosis by pyrazolo[3,4-d]pyrimidines in human leukemia cellsFabrizio Manetti, Annalisa Pucci, Matteo Magnani, et al.
Journal of Medicinal Chemistry|February 21, 2003
Design, synthesis, SAR, and molecular modeling studies of acylthiocarbamates: a novel series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors structurally related to phenethylthiazolylthiourea derivativesAngelo Ranise, Andrea Spallarossa, Silvia Schenone, et al.
Future Medicinal Chemistry|December 16, 2014
The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channelErika Nieddu, Benedetta Pollarolo, Marco T Mazzei, et al.
Pageof 18